Register
Login:
Share:
Email Facebook Twitter

Josh Mahony from IG sums up the forces driving markets and currencies Watch here

Leading commentator Josh Mahony from IG - are we seeing a US$ revaluation?


Premaitha Share Chat (NIPT)



Share Price: 8.25Bid: 8.00Ask: 8.50Change: 0.00 (0.00%)No Movement on Premaitha
Spread: 0.50Spread as %: 6.25%Open: 8.25High: 8.25Low: 8.25Yesterday’s Close: 8.25


Share Discussion for Premaitha


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


TruroTrader
Posts: 453
Off Topic
Opinion:No Opinion
Price:8.25
RE: U.K. Courts
Sat 21:46
Hallo Sheephatch,

I have not enough legal knowledge to understand your post. Could you please clarify.
 
juan_belfast
Posts: 1,226
Off Topic
Opinion:No Opinion
Price:8.25
RE: U.K. Courts
Fri 23:20
Not sure what your point is. We're likely to hear the result of our case in November...
Sheephatch
Posts: 1,227
Off Topic
Opinion:No Opinion
Price:8.25
U.K. Courts
Fri 17:51
Trial dates
“An important change to the management of patent cases” is how Henry Carr J described the Practice Statement of 7 December 2015109, the purpose of which is to bring patent cases on for trial where possible within 12 months of the claim being issued, something which the parties are expected to cooperate to achieve. Explaining that the policy of the new practice is to make the English courts more competitive with courts in Europe generally, and Germany in particular, in Celltrion v Biogen110 Henry Carr J used the practice direction to order a split trial of a multi-patent revocation action within the 12-month guideline.
e same Practice Statement was used by HHJ Hacon in Fuji lm v AbbVie111 to decide that it was not appropriate to adjourn the listing of a trial pending the determination of the jurisdictional challenge and strike out application. While it was true that the 12-month goal was not a straitjacket, the Judge ruled that it should not be set aside just because of the existence of the jurisdictional challenge and the strike out application.
e Napp v Dr Reddy’s proceedings are a remarkable example of the degree of expedition which can be achieved with adequate case management and the cooperation of the parties. Despite the complexity of the issues in suit, the case proceeded from issue of the claim to a nal decision on appeal within less than six months.
thetinman
Posts: 110
Off Topic
Opinion:No Opinion
Price:8.25
RE: Court Hearing
Thu 21:26
The waiting game continues. I can certainly wait another 11 weeks if a decision is forthcoming within this timescale, or earlier. I am actually looking forward to some certainty on this share.
twix386
Posts: 2,574
Off Topic
Opinion:No Opinion
Price:8.25
RE: Any Chance
Thu 14:12
Nope!

Move the decimal place as there's more chance it'll hit 6.05p, but let's hope we're near the low and last buying opp
Wanger18
Posts: 79
Off Topic
Opinion:No Opinion
Price:8.125
Any Chance
Thu 11:10
Of this hitting £6.50 so I can get my money back!! If only. Ended up in this via another company, think it was Vialogy. Had a fair chunk in them and it didn't work out. I switched off from this investment pretty much since that point and cling onto the hope that some day I will at least get a few quid back ! So fingers crossed it reaches the high end of some predictions on here and I will at least retrieve 25-30% of my original investment !
ramblingsid
Posts: 41
Off Topic
Opinion:No Opinion
Price:8.125
Court Hearing
Thu 11:09
Hemo

I emailed Investor Relations earlier in the week asking when the Judge indicated the Judgment would be given. They wrote back saying November. It would appear that the Judge wasn't more specific than that.

Interesting point about the EU investigation. Has anyone heard how the parties felt the case had gone?
Hemo
Posts: 158
Off Topic
Opinion:No Opinion
Price:8.125
Court hearing
Wed 18:23
I spoke today to a London solicitor of a firm that works on patents and is taking an interest in the premaitha vs illumina case.

She said the decision is expected in November but a settlement could still come at any time before that.

She also said her firm had heard the EU investigation into illumina is gathering pace.
notaflipper
Posts: 465
Off Topic
Opinion:No Opinion
Price:8.25
Esperite
Wed 13:30
Cryo-Save in Bosnia is a part of the Esperite group.

The link below though written in Bosnian
Shows that due to an overdue payment in Serbian Dinars the accounts of Cryo-Save in Bosnia have been blocked. So further pressure on Espirite after Genoma placed into bankruptcy by Premaitha. Confirmation of accounts being blocked have been made by (a) the Agency for Business Registers; and (b) The National Bank of Serbia. It says the accounts of Cryo-Save are blocked after financial problems and research and research into debt positions, but also for the registration of the biological owner of stored stem cells, as required by national rules. Customers are concerned about the unstable financial situation of Cryo-Save because they do not know what they are about the future of Cryo-Save, while paying for the storage of stem cells.

What this is means for Premaitha who knows. Perhaps this will mean the amount owed will be paid to release Genoma from bankruptcy. Otherwise it could mean that the continued problems at Espirite may mean that their former NIPT customers will choose Pemaitha’s IONA test directly.

http://www.bebac.com/vesti/blokirani-racuni-kompanije-cryo-save
twix386
Posts: 2,574
Off Topic
Opinion:No Opinion
Price:8.25
Very
12 Aug '17
Good posting sorcerer.

A welcome relief to the current general dialogue




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.